FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
PhaseBio Pharmaceuticals Inc [ PHAS ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 10/22/2018 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 10/22/2018 | C | 52,690 | A | (1) | 52,690 | I | By Hatteras Venture Partners I, LP(2) | ||
Common Stock | 10/22/2018 | C | 1,683,420 | A | (1) | 1,683,420 | I | By Hatteras Venture Partners III, LP(3) | ||
Common Stock | 10/22/2018 | P | 137,513 | A | $5 | 1,820,933 | I | By Hatteras Venture Partners III, LP(3) | ||
Common Stock | 10/22/2018 | C | 150,612 | A | (1) | 150,612 | I | By Hatteras Venture Affiliates III, LP(3) | ||
Common Stock | 10/22/2018 | P | 12,487 | A | $5 | 163,099 | I | By Hatteras Venture Affiliates III, LP(3) | ||
Common Stock | 10/22/2018 | C | 4,846 | A | (1) | 4,846 | I | By Catalysta Ventures, LLC(2) | ||
Common Stock | 10/22/2018 | C | 266,481 | A | (1) | 266,481 | I | By Venture Capital Multiplier Fund(3) | ||
Common Stock | 10/22/2018 | P | 150,000 | A | $5 | 416,481 | I | By Venture Capital Multiplier Fund(3) |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Warrants to Purchase Series B Preferred Stock | $0.12 | 10/22/2018 | X(4) | 19,061 | (5) | (5) | Series B Preferred Stock(1) | 19,061 | $0.00 | 0 | I | By Hatteras Venture Partners III, LP(3) | |||
Series B Preferred Stock | (1) | 10/22/2018 | X(4) | 19,061 | (1) | (1) | Common Stock | 19,061 | $0.12 | 1,045,222 | I | By Hatteras Venture Partners III, LP(3) | |||
Series B Preferred Stock | (1) | 10/22/2018 | S(4) | 458 | (1) | (1) | Common Stock | 458 | $5 | 1,044,764 | I | By Hatteras Venture Partners III, LP(3) | |||
Warrants to Purchase Series B Preferred Stock | $0.12 | 10/22/2018 | X(4) | 1,731 | (5) | (5) | Series B Preferred Stock(1) | 1,731 | $0.00 | 0 | I | By Hatteras Venture Affiliates III, LP(3) | |||
Series B Preferred Stock | (1) | 10/22/2018 | X(4) | 1,731 | (1) | (1) | Common Stock | 1,731 | $0.12 | 94,916 | I | By Hatteras Venture Affiliates III, LP(3) | |||
Series B Preferred Stock | (1) | 10/22/2018 | S(4) | 42 | (1) | (1) | Common Stock | 42 | $5 | 94,874 | I | By Hatteras Venture Affiliates III, LP(3) | |||
Warrants to Purchase Series C-1 Preferred Stock | $0.12 | 10/22/2018 | X(4) | 47,458 | (5) | (5) | Series C-1 Preferred Stock(1) | 47,458 | $0.00 | 0 | I | By Hatteras Venture Partners III, LP(3) | |||
Series C-1 Preferred Stock | (1) | 10/22/2018 | X(4) | 47,458 | (1) | (1) | Common Stock | 47,458 | $0.12 | 150,459 | I | By Hatteras Venture Partners III, LP(3) | |||
Series C-1 Preferred Stock | (1) | 10/22/2018 | S(4) | 1,139 | (1) | (1) | Common Stock | 1,139 | $5 | 149,320 | I | By Hatteras Venture Partners III, LP(3) | |||
Warrants to Purchase Series C-1 Preferred Stock | $0.12 | 10/22/2018 | X(4) | 4,309 | (5) | (5) | Series C-1 Preferred Stock(1) | 4,309 | $0.00 | 0 | I | By Hatteras Venture Affiliates III, LP(3) | |||
Series C-1 Preferred Stock | (1) | 10/22/2018 | X(4) | 4,309 | (1) | (1) | Common Stock | 4,309 | $0.12 | 13,662 | I | By Hatteras Venture Affiliates III, LP(3) | |||
Series C-1 Preferred Stock | (1) | 10/22/2018 | S(4) | 104 | (1) | (1) | Common Stock | 104 | $5 | 13,558 | I | By Hatteras Venture Affiliates III, LP(3) | |||
Warrants to Purchase Series C-1 Preferred Stock | $0.12 | 10/22/2018 | X(4) | 41,414 | (5) | (5) | Series C-1 Preferred Stock(1) | 41,414 | $0.00 | 0 | I | By Venture Capital Multiplier Fund(3) | |||
Series C-1 Preferred Stock | (1) | 10/22/2018 | X(4) | 41,414 | (1) | (1) | Common Stock | 41,414 | $0.12 | 41,414 | I | By Venture Capital Multiplier Fund(3) | |||
Series C-1 Preferred Stock | (1) | 10/22/2018 | S(4) | 994 | (1) | (1) | Common Stock | 994 | $5 | 40,420 | I | By Venture Capital Multiplier Fund(3) | |||
Series 1 Preferred Stock | (1) | 10/22/2018 | C | 52,690 | (1) | (1) | Common Stock | 52,690 | $0.00 | 0 | I | By Hatteras Venture Partners I, LP(2) | |||
Series 1 Preferred Stock | (1) | 10/22/2018 | C | 42,530 | (1) | (1) | Common Stock | 42,530 | $0.00 | 0 | I | By Hatteras Venture Partners III, LP(3) | |||
Series 1 Preferred Stock | (1) | 10/22/2018 | C | 3,862 | (1) | (1) | Common Stock | 3,862 | $0.00 | 0 | I | By Hatteras Venture Affiliates III, LP(3) | |||
Series 1 Preferred Stock | (1) | 10/22/2018 | C | 4,846 | (1) | (1) | Common Stock | 4,846 | $0.00 | 0 | I | By Catalysta Ventures, LLC(2) | |||
Series AA Preferred Stock | (1) | 10/22/2018 | C | 174,699 | (1) | (1) | Common Stock | 174,699 | $0.00 | 0 | I | By Hatteras Venture Partners III, LP(3) | |||
Series AA Preferred Stock | (1) | 10/22/2018 | C | 13,609 | (1) | (1) | Common Stock | 13,609 | $0.00 | 0 | I | By Hatteras Venture Affiliates III, LP(3) | |||
Series B Preferred Stock | (1) | 10/22/2018 | C | 1,044,764 | (1) | (1) | Common Stock | 1,044,764 | $0.00 | 0 | I | By Hatteras Venture Partners III, LP(3) | |||
Series B Preferred Stock | (1) | 10/22/2018 | C | 94,874 | (1) | (1) | Common Stock | 94,874 | $0.00 | 0 | I | By Hatteras Venture Affiliates III, LP(3) | |||
Series C-1 Preferred Stock | (1) | 10/22/2018 | C | 149,320 | (1) | (1) | Common Stock | 149,320 | $0.00 | 0 | I | By Hatteras Venture Partners III, LP(3) | |||
Series C-1 Preferred Stock | (1) | 10/22/2018 | C | 13,558 | (1) | (1) | Common Stock | 13,558 | $0.00 | 0 | I | By Hatteras Venture Affiliates III, LP(3) | |||
Series C-1 Preferred Stock | (1) | 10/22/2018 | C | 40,420 | (1) | (1) | Common Stock | 40,420 | $0.00 | 0 | I | By Venture Capital Multiplier Fund(3) | |||
Series D Preferred Stock | (1) | 10/22/2018 | C | 272,107 | (1) | (1) | Common Stock | 272,107 | $0.00 | 0 | I | By Hatteras Venture Partners III, LP(3) | |||
Series D Preferred Stock | (1) | 10/22/2018 | C | 24,709 | (1) | (1) | Common Stock | 24,709 | $0.00 | 0 | I | By Hatteras Venture Affiliates III, LP(3) | |||
Series D Preferred Stock | (1) | 10/22/2018 | C | 226,061 | (1) | (1) | Common Stock | 226,061 | $0.00 | 0 | I | By Venture Capital Multiplier Fund(3) |
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
Explanation of Responses: |
1. Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date. |
2. Catalysta Ventures, LLC ("Catalysta") is under common control with Hatteras Venture Advisors III, LLC ("HVA III"). Catalysta is the general partner of Hatteras Venture Partners I, LP ("HVP I"). The securities held directly by HVP I are indirectly held by Catalysta, which may be deemed to share voting and dispositive power with regard to the securities directly held by HVP I. Catalysta disclaims beneficial ownership of the securities held by HVP I except to the extent of its pecuniary interest therein. The individual managers of Catalysta are Clay B. Thorp and John Crumpler (the "Managers"), who may be deemed to share voting and dispositive power with regard to the securities held directly by Catalysta and HVP I. The Managers disclaim beneficial ownership of the securities held by Catalysta and HVP I except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately. |
3. HVA III is the general partner of Hatteras Venture Partners III, LP ("HVP III"), Hatteras Venture Affiliates III, LP ("HV Affiliates") and Venture Capital Multiplier Fund ("Multiplier Fund"). The securities held directly by HVP III, HV Affiliates and Multiplier Fund are indirectly held by HVA III. The individual managers of HVA III are Clay B. Thorp, Robert A. Ingram, Kenneth B. Lee, Douglas Reed, MD and John Crumpler (the "GP Directors"). HVA III and the GP Directors may be deemed to share voting and dispositive power with regard to the securities directly held by HVP III, HV Affiliates and Multiplier Fund. HVA III and the GP Directors disclaim beneficial ownership of the securities held by HVP III, HV Affiliates and Multiplier Fund except to the extent of their pecuniary interest therein. Mr. Thorp is a director of the Issuer and files Section 16 reports separately. |
4. Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering. |
5. The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering. |
Remarks: |
/s/ Darren K. DeStefano, Attorney-in-Fact for Hatteras Venture Advisors III, LLC | 10/24/2018 | |
/s/ Darren K. DeStefano, Attorney-in-Fact for Hatteras Venture Partners III, LP | 10/24/2018 | |
/s/ Darren K. DeStefano, Attorney-in-Fact for Hatteras Venture Affiliates III, LP | 10/24/2018 | |
/s/ Darren K. DeStefano, Attorney-in-Fact for Hatteras Venture Partners I, LP | 10/24/2018 | |
/s/ Darren K. DeStefano, Attorney-in-Fact for Catalysta Ventures, LLC | 10/24/2018 | |
/s/ Darren K. DeStefano, Attorney-in-Fact for Venture Capital Multiplier Fund | 10/24/2018 | |
/s/ Darren K. DeStefano, Attorney-in-Fact for Robert A. Ingram | 10/24/2018 | |
/s/ Darren K. DeStefano, Attorney-in-Fact for Kenneth B. Lee | 10/24/2018 | |
/s/ Darren K. DeStefano, Attorney-in-Fact for Douglas Reed | 10/24/2018 | |
/s/ Darren K. DeStefano, Attorney-in-Fact for John Crumpler | 10/24/2018 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |